370 related articles for article (PubMed ID: 11390664)
1. Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.
Leppä S; Eriksson M; Saffrich R; Ansorge W; Bohmann D
Mol Cell Biol; 2001 Jul; 21(13):4369-78. PubMed ID: 11390664
[TBL] [Abstract][Full Text] [Related]
2. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
Eriksson M; Taskinen M; Leppä S
J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
[TBL] [Abstract][Full Text] [Related]
3. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation.
Leppä S; Saffrich R; Ansorge W; Bohmann D
EMBO J; 1998 Aug; 17(15):4404-13. PubMed ID: 9687508
[TBL] [Abstract][Full Text] [Related]
5. Role of c-Jun concentration in neuronal cell death.
Rössler OG; Steinmüller L; Giehl KM; Thiel G
J Neurosci Res; 2002 Dec; 70(5):655-64. PubMed ID: 12424733
[TBL] [Abstract][Full Text] [Related]
6. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
[TBL] [Abstract][Full Text] [Related]
7. AP-1 and ATF-2 are constitutively activated via the JNK pathway in Theileria parva-transformed T-cells.
Botteron C; Dobbelaere D
Biochem Biophys Res Commun; 1998 May; 246(2):418-21. PubMed ID: 9610375
[TBL] [Abstract][Full Text] [Related]
8. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
9. The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.
Fan M; Goodwin ME; Birrer MJ; Chambers TC
Cancer Res; 2001 Jun; 61(11):4450-8. PubMed ID: 11389075
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase.
Koyuturk M; Ersoz M; Altiok N
Neurosci Lett; 2004 Nov; 370(2-3):212-7. PubMed ID: 15488325
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction.
Eckhoff DE; Smyth CA; Eckstein C; Bilbao G; Young CJ; Thompson JA; Contreras JL
Surgery; 2003 Aug; 134(2):169-79. PubMed ID: 12947315
[TBL] [Abstract][Full Text] [Related]
12. Activation of c-Jun and ATF-2 in primate motor cranial nerve nuclei is not associated with apoptosis following axotomy.
Colby GP; Coon AL; Connolly ES; Ambron RT
Exp Neurol; 2005 Jul; 194(1):57-65. PubMed ID: 15899243
[TBL] [Abstract][Full Text] [Related]
13. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
14. AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun.
Grimm C; Wenzel A; Behrens A; Hafezi F; Wagner EF; Remé CE
Cell Death Differ; 2001 Aug; 8(8):859-67. PubMed ID: 11526439
[TBL] [Abstract][Full Text] [Related]
15. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.
Karin M; Gallagher E
IUBMB Life; 2005; 57(4-5):283-95. PubMed ID: 16036612
[TBL] [Abstract][Full Text] [Related]
16. Jun and JNK kinase are activated in thymocytes in response to VM26 and radiation but not glucocorticoids.
Testolin L; Carson C; Wang Y; Walker PR; Armato U; Sikorska M
Exp Cell Res; 1997 Feb; 230(2):220-32. PubMed ID: 9024781
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor c-Jun activation represses mdr-1 gene expression.
Miao ZH; Ding J
Cancer Res; 2003 Aug; 63(15):4527-32. PubMed ID: 12907627
[TBL] [Abstract][Full Text] [Related]
18. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
19. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis.
Leppä S; Bohmann D
Oncogene; 1999 Nov; 18(45):6158-62. PubMed ID: 10557107
[TBL] [Abstract][Full Text] [Related]
20. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
